Related Experiment Videos

Mild renal dysfunction predicts in-hospital mortality and post-discharge survival following cardiac surgery

Neil J Howell1, Bruce E Keogh, Robert S Bonser

  • 1Department of Cardiothoracic Surgery, University Hospital Birmingham, UK.

Insights

Mild renal dysfunction significantly increases mortality risk in adult cardiac surgery patients. This chronic kidney disease (CKD) impacts both in-hospital and long-term survival outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Surgical Outcomes

Background:

  • Preoperative renal dysfunction is a growing concern in adult cardiac surgery.
  • Existing risk stratification systems may not adequately account for mild renal impairment.

Purpose of the Study:

  • To evaluate the association between preoperative chronic kidney disease (CKD) stages and in-hospital mortality.
  • To assess the impact of CKD on late survival outcomes after adult cardiac surgery.

Main Methods:

  • Analysis of prospectively collected data from 7621 adult cardiac surgery patients (CABG, valve, or combined procedures).
  • Preoperative estimated glomerular filtration rate calculated using the Cockcroft-Gault formula.
  • Patients categorized into four CKD stages; late survival data from the UK Central Cardiac Audit Database.

Main Results:

  • A stepwise increase in operative mortality was observed with advancing CKD stages.
  • CKD stage was an independent predictor of in-hospital mortality (Class 2-4: OR 1.45-7.5).
  • CKD stage independently predicted late survival (Class 2-4: HR 1.2-3.2), with a median follow-up of 42 months.

Conclusions:

  • Even mild renal dysfunction (CKD stages) is a significant independent predictor of mortality.
  • Preoperative renal function assessment is crucial for risk stratification in adult cardiac surgery.
  • Findings highlight the need to incorporate renal function into cardiac surgery risk models.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...